Cargando…
EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
Autores principales: | Sesboüé, R, Le Pessot, F, Di Fiore, F, Frebourg, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261662/ https://www.ncbi.nlm.nih.gov/pubmed/22187031 http://dx.doi.org/10.1038/bjc.2011.570 |
Ejemplares similares
-
Reply: EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?
por: Ålgars, A, et al.
Publicado: (2012) -
Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer
por: Fiore, F Di, et al.
Publicado: (2008) -
Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer
por: Di Fiore, F, et al.
Publicado: (2010) -
Genetic variations of the A13/A14 repeat located within the EGFR 3′ untranslated region have no oncogenic effect in patients with colorectal cancer
por: Sarafan-Vasseur, Nasrin, et al.
Publicado: (2013) -
Somatic copy number alterations are associated with EGFR amplification and shortened survival in patients with primary glioblastoma
por: Muñoz-Hidalgo, Lisandra, et al.
Publicado: (2019)